Original post: Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit
Original post: Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit
Read the original post: Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older
Originally posted here: Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson
Visit link: Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical...
Go here to read the rest: DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
See the original post: Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended...
See original here: Roche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study
Read the original: Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and...
Go here to read the rest: Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
Read more: NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
Recent Comments